1. Home
  2. UBS vs SYK Comparison

UBS vs SYK Comparison

Compare UBS & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UBS Group AG Registered

UBS

UBS Group AG Registered

HOLD

Current Price

$38.41

Market Cap

128.4B

Sector

Finance

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$364.59

Market Cap

141.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBS
SYK
Founded
1862
1941
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.4B
141.2B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
UBS
SYK
Price
$38.41
$364.59
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$60.30
$431.08
AVG Volume (30 Days)
2.5M
1.7M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
1.40%
0.95%
EPS Growth
N/A
8.25
EPS
N/A
8.40
Revenue
N/A
$25,116,000,000.00
Revenue This Year
$9.13
$9.86
Revenue Next Year
$3.47
$8.39
P/E Ratio
$17.22
$44.11
Revenue Growth
N/A
11.16
52 Week Low
$25.75
$329.16
52 Week High
$49.36
$404.87

Technical Indicators

Market Signals
Indicator
UBS
SYK
Relative Strength Index (RSI) 25.05 42.79
Support Level $37.41 $349.06
Resistance Level $38.81 $375.26
Average True Range (ATR) 0.71 8.02
MACD -0.26 -1.51
Stochastic Oscillator 9.39 27.00

Price Performance

Historical Comparison
UBS
SYK

About UBS UBS Group AG Registered

UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: